This week’s episode of “WisBusiness the Podcast” is with returning guest Alex Vodenlich, president and CEO of Plumb Pharmaceuticals.
The Madison-based company has developed and patented a technology platform for long-duration drug release, starting with a formulation for an opioid addiction medication. Over the past year and a half, since Vodenlich last came on the podcast, the business has been working on optimizing and testing its naltrexone product.
“We have tested it to prove out that the duration is as long as we say it is,” he said. “Which, today I can tell you that we’ve improved it from four weeks to eight weeks … and we’ve done so using materials that are already seen or have been approved by the FDA, as has naltrexone.”
;
